ClinicalTrials.Veeva

Menu

Prevalence of Thrombosis in COVID-Patients

U

University Hospital Augsburg

Status

Completed

Conditions

Covid19

Treatments

Diagnostic Test: duplex sonography

Study type

Observational

Funder types

Other

Identifiers

NCT04615026
COVID Thrombose

Details and patient eligibility

About

Examination of the prevalence of thrombosis in COVID-patients, especially in an out-patient setting. Assessment by duplex sonography. If thrombosis is detected, we will correlate it with immunity status. Assessment of health issues and cognitive function as late complication after infection.

Enrollment

525 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • SARS CoV 2 positive swap, at least 4 weeks after infection

Exclusion criteria

  • under 18 years old no consent anemia

Trial design

525 participants in 1 patient group

COVID 19 patients
Description:
all patients with positive SARS-CoV 2 swap
Treatment:
Diagnostic Test: duplex sonography

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems